It is easy to talk about due diligence in the abstract, but it is much harder to practice what you preach. One of the hardest things about early stage investing is that it is really risky – if you don’t have some suspension of disbelief, and you obsess too much about cataloging every risk, you will never get a deal done. As a way of wrapping up this series of articles with a review, let’s take a look at a few common mistakes and see what we can learn from them.
- A Field Guide to Tourist Capital
- Your Brilliant Solution is Just the Start in Fundraising.
- Pyx Health Named to the Inc. 5000 List for the 5th Year in row
- The K-Shaped Meat Grinder – What a Record Venture Market Means for Regions That Will Never See It
- Linshom Medical Awarded Commercialization Innovation Grant
- Somewhere Right Now a Surgeon is Learning a Procedure for the Very First Time on a Real Person. ReSuture Changes This!
- Are Ecosystem Leaders Wasting Money on Accelerators?
- Regional Ecosystems Operate Inside an Accountability Vacuum
- NuvOx Therapeutics Receives FDA Fast Track Designation to NanO₂™ for the Treatment of Acute Ischemic Stroke
- $200MM and Counting: What’s Next for the Movement to Invest in Women Entrepreneurs
